A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease



Scott, Robert A, Freitag, Daniel F, Li, Li, Chu, Audrey Y, Surendran, Praveen, Young, Robin, Grarup, Niels, Stancakova, Alena, Chen, Yuning, Varga, Tibor V
et al (show 140 more authors) (2016) A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. SCIENCE TRANSLATIONAL MEDICINE, 8 (341).

[img] Text
aad3744_ArticleContent_v8_MLF_RS_accepted_cleaned.docx - Accepted Version

Download (239kB)
[img] Text
aad3744_SupplementalMaterial_v5_MLF_RS_cleaned.docx - Accepted Version

Download (252kB)
[img] Text
Rev_Figure4_060116.pdf - Accepted Version

Download (18kB)
[img] Text
Rev2_Figure1_300316.pdf - Accepted Version

Download (90kB)
[img] Text
Rev2_Figure2_300316.pdf - Accepted Version

Download (72kB)
[img] Text
Rev2_Figure3_300316.pdf - Accepted Version

Download (53kB)
[img] Spreadsheet
Rev3_Updated_Supplementary tables_with_refs_080516.xlsx - Accepted Version

Download (55kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 22 Jun 2016 08:54
Last Modified: 23 Nov 2020 20:19
DOI: 10.1126/scitranslmed.aad3744
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3001803